The pharma industry and its Republican allies in Congress are openly signaling their plans obstruct at every turn as the Biden administration looks to begin implementing a recently passed law allowing Medicare to negotiate drug prices for the first time in its history. They’re using an argument debunked many times before money buys politicians.